Â鶹Éçmadou

About this webinar:

Opioid agonist treatment (OAT) is a key evidence-based response to opioid dependence, yet challenges around access and retention persist. In this webinar, Maud Groothuizen will present insights from a mixed-methods study conducted in New South Wales exploring how people engage with OAT and what shapes their treatment journeys. Drawing on survey data and lived experience narratives, the presentation will examine how individuals navigate entry into treatment, experiences within services, and the factors that may influence ongoing engagement or early dropout.

About the speaker:

Maud Groothuizen is a Global Health master's student at Vrije Universiteit Amsterdam with a BSc in Sociology and a strong interest in mental health and addiction care. She previously conducted research on non-medical prescription opioid use among young adults in Denmark and worked as a program assistant at the Trimbos Institute, the Netherlands Institute of Mental Health and Addiction. Currently, she is based at the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales in Sydney, where she writes her master's thesis focussing on barriers and facilitators to engagement with opioid agonist treatment (OAT).